AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Supernus Triggers MACD Death Cross, KDJ Death Cross on 15-Minute Chart.
ByAinvest
Monday, Jul 7, 2025 3:37 pm ET1min read
Based on the analysis of Supernus's 15-minute chart, a MACD Death Cross and KDJ Death Cross were triggered on July 7th, 2025 at 15:30. This indicates that the stock price has a high potential to continue declining, as the momentum of the stock price is shifting towards the downside and may lead to further decreases.
Health care stocks experienced a mixed performance on Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each climbing 1.4% [1]. The iShares Biotechnology ETF (IBB) added 0.9% to the gains.RedHill Biopharma (RDHL) shares rose 5.8% after the company announced it has started patient recruitment for a phase 2 trial of opaganib in combination with darolutamide for the treatment of metastatic castrate-resistant prostate cancer [1]. AstraZeneca (AZN) gained 2.2% following reports that its Chief Executive, Pascal Soriot, has expressed a preference to move the company's stock market listing to the US [1].
IGM Biosciences (IGMS) shares jumped 15% after the firm announced it has agreed to be acquired by Concentra Biosciences [1]. Sage Therapeutics (SAGE) shares were down 0.2% as the company agreed to be acquired by Supernus Pharmaceuticals (SUPN), with Supernus adding 0.9% [1].
Based on the analysis of Supernus's 15-minute chart, a MACD Death Cross and KDJ Death Cross were triggered on July 7th, 2025, at 15:30. This indicates that the stock price has a high potential to continue declining, as the momentum of the stock price is shifting towards the downside and may lead to further decreases [2].
References:
[1] https://finance.yahoo.com/news/sector-health-care-stocks-rise-195638369.html
[2] Based on the analysis of Supernus's 15-minute chart, a MACD Death Cross and KDJ Death Cross were triggered on July 7th, 2025, at 15:30. This indicates that the stock price has a high potential to continue declining, as the momentum of the stock price is shifting towards the downside and may lead to further decreases.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet